Adaptin Bio (APTN) Change in Account Payables (2023 - 2026)

Adaptin Bio (APTN) has 4 years of Change in Account Payables data on file, last reported at -$140781.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables rose 79.54% year-over-year to -$140781.0; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 810.26% YoY), and the FY2025 full-year result was $496910.0, down 54.02% from the prior year.
• Change in Account Payables declined to -$140781.0 in Q1 2026, from $174014.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $671507.0 in Q3 2025 to a low of -$688124.0 in Q1 2025.
• A 4-year average of $131397.5 and a median of $174014.0 in 2025 frame the typical range for Change in Account Payables.
• Across the five-year window, Change in Account Payables jumped 10241.25% in 2024 and tumbled 347.62% in 2025, its largest moves.
• Tracing APTN's Change in Account Payables over 4 years: stood at $4250.0 in 2023, then soared by 10015.27% to $429899.0 in 2024, then plunged by 59.52% to $174014.0 in 2025, then sank by 180.9% to -$140781.0 in 2026.
• Business Quant data shows APTN's Change in Account Payables at -$140781.0 in Q1 2026, $174014.0 in Q4 2025, and $671507.0 in Q3 2025.